Non-targeted Metabolomics Analysis of Fuling Yunhua Granules in Treatment of Type 2 Diabetes Mellitus Rats

TIAN Mengyao; LUO Keke; WANG Mengxiao; HU Tianbao; LI Hongmei; HE Zongyuan; YANG Lixin; HAO Liyu; SI Nan; LIU Yuyang; BIAN Baolin; WANG Hongjie; ZHOU Yanyan

doi:10.13422/j.cnki.syfjx.20250661

您当前的位置：

首页 >

文章列表页 >

Non-targeted Metabolomics Analysis of Fuling Yunhua Granules in Treatment of Type 2 Diabetes Mellitus Rats

更新时间：2025-05-28

- Non-targeted Metabolomics Analysis of Fuling Yunhua Granules in Treatment of Type 2 Diabetes Mellitus Rats
  增强出版
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 23, Pages: 195-204(2024)
- 作者机构：
  
  1.中国中医科学院中药研究所，北京 100700
  2.北京精医和生医药科技有限公司，北京 100176
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20250661
  CLC： R22;R28;R587.1;Q493.9
- Received：25 June 2024，
  
  Online First：23 September 2024，
  
  Published：05 December 2024
- 稿件说明：
移动端阅览
田孟尧,罗珂珂,王梦晓等.茯苓运化颗粒治疗2型糖尿病大鼠的非靶向代谢组学分析[J].中国实验方剂学杂志,2024,30(23):195-204.

TIAN Mengyao,LUO Keke,WANG Mengxiao,et al.Non-targeted Metabolomics Analysis of Fuling Yunhua Granules in Treatment of Type 2 Diabetes Mellitus Rats[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(23):195-204.
田孟尧,罗珂珂,王梦晓等.茯苓运化颗粒治疗2型糖尿病大鼠的非靶向代谢组学分析[J].中国实验方剂学杂志,2024,30(23):195-204. DOI： 10.13422/j.cnki.syfjx.20250661.

TIAN Mengyao,LUO Keke,WANG Mengxiao,et al.Non-targeted Metabolomics Analysis of Fuling Yunhua Granules in Treatment of Type 2 Diabetes Mellitus Rats[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(23):195-204. DOI： 10.13422/j.cnki.syfjx.20250661.

摘要

目的

基于非靶向代谢组学技术，分析茯苓运化颗粒对2型糖尿病（T2DM）大鼠血清内源性差异代谢物的调控作用，明确茯苓运化颗粒发挥改善T2DM作用的代谢调控途径。

方法

70只SD级大鼠，雌雄各半，随机分为空白组、模型组、茯苓运化颗粒高、中、低剂量组（以生药量计，20.70、10.35、5.18 g·kg

-1

）及阳性药组（盐酸吡格列酮片8.1 mg·kg

-1

）。除空白组外，其余各组均以高糖高脂饲料喂养联合腹腔注射链脲佐菌素（STZ）构建T2DM大鼠模型。造模成功后，给药组灌胃给予相应药物治疗，空白组及模型组灌胃等体积生理盐水，1次/d，共给药28 d。给药期间检测各组大鼠空腹血糖、糖化血红蛋白A1c（GHbA1c）水平，给药结束后采用苏木素-伊红（HE）染色观察大鼠胰腺组织的病理形态变化。采用超高效液相色谱-线性离子阱-静电场轨道阱高分辨质谱法（UPLC-LTQ-Orbitrap MS）检测大鼠血清内源性代谢物水平，通过主成分分析（PCA）和正交偏最小二乘法-判别分析（OPLS-DA）处理数据。利用人类代谢组数据库（HMDB）和京都基因与基因组百科全书（KEGG）鉴定差异代谢物，筛选变量重要性投影（VIP）值

1，

0.05，差异倍数（FC）

0.6或FC

1的差异代谢物，并通过MetaboAnalyst 5.0对筛选的差异代谢物进行代谢通路富集分析。通过受试者工作特征（ROC）曲线对筛选得到的差异代谢物进行诊断评价。

结果

与空白组比较，模型组大鼠空腹血糖水平显著升高（

0.01），GHbA1c含量有增高趋势，但差异无统计学意义，大鼠胰腺组织明显损伤，胰岛数量减少，胰岛

细胞明显减少、萎缩、肿大；与模型组比较，茯苓运化颗粒高剂量组和阳性药组大鼠给药2周后，空腹血糖明显降低（

0.05，

0.01），茯苓运化颗粒高剂量组大鼠GHbA1c含量明显降低（

0.05），茯苓运化颗粒高、中、低剂量组大鼠胰腺组织病变减轻。非靶向代谢组学结果显示，与空白组比较，模型组共有46个差异代谢物发生明显变化；通路富集分析发现，T2DM主要影响了大鼠体内初级胆汁酸生物合成、

-氨基酸代谢、类固醇激素生物合成、甘油磷脂代谢等生物过程。与模型组比较，茯苓运化颗粒高剂量组中8个差异代谢物的水平明显回调，通路富集分析发现，主要涉及

-氨基酸代谢，视黄醇的新陈代谢，甘氨酸、丝氨酸和苏氨酸的代谢，色氨酸代谢等代谢途径。ROC曲线进一步分析发现，11-顺视黄醇、

-哌啶酸、

-丝氨酸、硫酸对甲酚4个特征性差异标志物对于茯苓运化颗粒治疗T2DM具有较高的诊断价值。

结论

茯苓运化颗粒可改善T2DM大鼠症状，其机制可能与调节差异代谢物，调控氨基酸类代谢和视黄醇代谢等通路相关。

Abstract

Objective

Based on non-targeted metabolomics， to analyze the regulation of endogenous differential metabolites in serum of type 2 diabetes mellitus（T2DM） rats by Fuling Yunhua granules， and to clarify the metabolic pathways through which this granules exerted its effect on improving T2DM.

Method

Seventy SD rats， half male and half female， were randomly divided into the control group， model group， and high， medium， low dose groups of Fuling Yunhua granules（2

0.70， 10.35， 5.18 g·kg

-1

in raw drug amount） and the positive drug group（pioglitazone hydrochloride tablets， 8.1 mg·kg

-1

）. Except for the control group， other groups were fed with high-sugar and high-fat diet combined with intraperitoneal injection of streptozotocin（STZ） to establish a T2DM rat model. After successful modeling， the treatment groups were administered the corresponding drugs by gavage， and the control group and model group were treated with an equal volume of saline by gavage， once/d， for 28 d. Fasting blood glucose（FBG） and glycosylated hemoglobin A1c（GHbA1c） levels were measured in all groups of rats during the administration period， and hematoxylin-eosin（HE） staining was used to observe the pathomorphological changes in the pancreatic tissues of rats at the end of the administration period. The endogenous metabolite levels in rat serum were detected by ultra-performance liquid chromatography-linear ion trap-electrostatic field orbitrap high-resolution mass spectrometry（UPLC-LTQ-Orbitrap MS）， and the data were processed using principal component analysis（PCA） and orthogonal partial least squares-discriminant analysis（OPLS-DA）. Differential metabolites were identified by the Human Metabolome Database（HMDB） and the Kyoto Encyclopedia of Genes and Genomes（KEGG）， and screened for differential metabolites with variable importance in the projection（VIP） value

1，

0.05， and fold change（FC）

0.6 or FC

1. And the metabolic pathway enrichment analysis of the screened differential metabolites was performed by MetaboAnalyst 5.0， then the screened differential metabolites were diagnosed and evaluated by the receiver operating characteristic（ROC） curves.

Result

Compared with the control group， the FBG level of rats in the model group increased significantly（

0.01）， the GHbA1c content tended to increase， but the difference was not statistically significant， and the pancreatic tissue of rats was obviously damag

ed， the number of pancreatic islets decreased， and the pancreatic

-cells were obviously reduced， atrophied and enlarged. Compared with the model group， the FBG levels of rats in the high dose group of Fuling Yunhua granules and the positive drug group were significantly reduced after 2 weeks of administration（

0.05，

0.01）， the GHbA1c content of rats in the high dose group of Fuling Yunhua granules was significantly reduced（

0.05）， and the pancreatic tissue lesions of rats in the different dose groups of Fuling Yunhua granules were reduced. The results of non-targeted metabolomics showed that 46 differential metabolites were significantly changed in the model group compared with the blank group. Pathway enrichment analysis found that T2DM mainly affected biological processes including biosynthesis of primary bile acid，

-amino acid metabolism， steroid hormone biosynthesis， and glycerophospholipid metabolism in rats. Compared with the model group， the levels of 8 differential metabolites in the high dose group of Fuling Yunhua granules were significantly adjusted， and the pathway enrichment analysis found that

-amino acid metabolism， retinol metabolism， glycine， serine and threonine metabolism， tryptophan metabolism and other metabolic pathways were mainly involved. ROC curves further analysis revealed that the four characteristic differential markers of 11-

cis

-retinol，

-piperidinic acid，

-serine， and

-cresol sulfate had high diagnostic value for the treatment of T2DM with Fuling Yunhua granules.

Conclusion

Fuling Yunhua granules can improve the symptoms of T2DM rats by regulating the amino acid metabolic and retinol metabolic pathways through the modulation of endogenous differential metabolites.

关键词

Keywords

references

TOBIAS D K ， MERINO J ， AHMAD A ， et al . Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine ［J］. Nat Med ， 2023 ， 29 （ 10 ）： 2438 - 2457 .

LING C ， BACOS K ， RÖNN T . Epigenetics of type 2 diabetes mellitus and weight change-A tool for precision medicine？［J］. Nat Rev Endocrinol ， 2022 ， 18 （ 7 ）： 433 - 448 .

LING C . Epigenetic regulation of insulin action and secretion-role in the pathogenesis of type 2 diabetes ［J］. J Intern Med ， 2020 ， 288 （ 2 ）： 158 - 167 .

GBD 2021 DIABETES COLLABORATORS . Global，regional，and national burden of diabetes from 1990 to 2021，with projections of prevalence to 2050：A systematic analysis for the Global Burden of Disease Study 2021 ［J］. Lancet ， 2023 ， 402 （ 10397 ）： 203 - 234 .

LANCET T . Diabetes：A dynamic disease ［J］. Lancet ， 2017 ， 389 （ 10085 ）： 2163 .

REDONDO M J ， HAGOPIAN W A ， ORAM R ， et al . The clinical consequences of heterogeneity within and between different diabetes types ［J］. Diabetologia ， 2020 ， 63 （ 10 ）： 2040 - 2048 .

牛亚平，柴三葆，马璟籽，等 . 基础胰岛素联合口服降糖药治疗效果不佳的2型糖尿病患者的治疗策略选择：伞形评价［J］. 药物流行病学杂志， 2023 ， 32 （ 11 ）： 1275 - 1284 .

中华医学会糖尿病学分会 . 中国2型糖尿病防治指南（2017年版）［J］. 中国实用内科杂志， 2018 ， 38 （ 4 ）： 292 - 344 .

姚思丹 . 米格列醇+格列吡嗪治疗2型糖尿病患者的临床疗效及对血糖水平的影响［J］. 中国医药指南， 2023 ， 21 （ 36 ）： 81 - 83，87 .

姜立娟，李玉国，崔巍，等 . PI3K/Akt信号通路参与中药防治2型糖尿病胰岛素抵抗的研究进展［J］. 中华中医药杂志， 2021 ， 36 （ 9 ）： 5405 - 5408 .

CAI W ， GUAN Y ， ZHOU Y ， et al . Detection and characterization of the metabolites of rutaecarpine in rats based on ultra-high-performance liquid chromatography with linear ion trap-orbitrap mass spectrometer ［J］. Pharm Biol ， 2017 ， 55 （ 1 ）： 294 - 298 .

UCHIDA H ， ITABASHI Y ， WATANABEA R ， et al . Detection and identification of furan fatty acids from fish lipids by high-performance liquid chromatography coupled to electrospray ionization quadrupole time-of-flight mass spectrometry ［J］. Food Chem ， 2018 ， 252 ： 84 - 91 .

黄雪柠，赵夏，候梦雨，等 . 基于非靶向代谢组学的肝阴虚小鼠模型评价［J］. 中国实验方剂学杂志， 2024 ， 30 （ 5 ）： 118 - 125 .

洪银洁，涂文玲，朱景茹，等 . 基于代谢组学探讨柴芍六君汤对肝郁脾虚型慢性萎缩性胃炎大鼠的中枢调节作用［J］. 中国实验方剂学杂志， 2024 ， 30 （ 2 ）： 148 - 155 .

田孟尧，王梦晓，罗珂珂，等 . 地黄宝源颗粒治疗糖尿病药效评价及基于UHPLC-LTQ-Orbitrap MS的成分分析和体内分布［J］. 中国中药杂志， 2024 ， 49 （ 10 ）： 2783 - 2797 .

DELTOMBE O ， VAN B W ， GLORIEUXl G ， et al . Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis ［J］. Toxins （Basel）， 2015 ， 7 （ 10 ）： 3933 - 3946 .

GRYP T ， VANHOLDER R ， VANEECHOUTTE M ， et al . p -Cresyl sulfate ［J］. Toxins （Basel）， 2017 ， 9 （ 2 ）： 52 .

KOPPE L ， PILLON N J ， VELLA R E ， et al . p -Cresyl sulfate promotes insulin resistance associated with CKD ［J］. J Am Soc Nephrol ， 2013 ， 24 （ 1 ）： 88 - 99 .

BRIAL F ， ALZAID F ， SONOMURA K ， et al . The Natural metabolite 4-cresol improves glucose homeostasis and enhances β -cell function ［J］. Cell Rep ， 2020 ， 30 （ 7 ）： 2306 - 2320 .

LIN H H ， HUANG C C ， LIN T Y ， et al . p -Cresol mediates autophagic cell death in renal proximal tubular cells ［J］. Toxicol Lett ， 2015 ， 234 （ 1 ）： 20 - 29 .

BROCCA A ， VIRZI G M ， DE C M ， et al . Cytotoxic effects of p -cresol in renal epithelial tubular cells ［J］. Blood Purif ， 2013 ， 36 （ 3-4 ）： 219 - 225 .

GROSS P ， MASSY Z A ， HENAUT L ， et al . Para-cresyl sulfate acutely impairs vascular reactivity and induces vascular remodeling ［J］. J Cell Physiol ， 2015 ， 230 （ 12 ）： 2927 - 2935 .

RAZQUIN C ， RUIZ-CANELA M ， CLISH C B ， et al . Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study：Results from two case-cohort studies ［J］. Cardiovasc Diabetol ， 2019 ， 18 （ 1 ）： 151 .

VATANEN T ， ANG Q Y ， SIEGWALD L ， et al . A distinct clade of Bifidobacterium longum in the gut of Bangladeshi children thrives during weaning ［J］. Cell ， 2022 ， 185 （ 23 ）： 4280 - 4297 .

YE L ， CHEN H ， WANG J ， et al . Aflatoxin B 1 -induced liver pyroptosis is mediated by disturbing the gut microbial metabolites：The roles of pipecolic acid and norepinephrine ［J］. J Hazard Mater ， 2024 ， 474 ： 134822 .

NG D P ， SALIM A ， LIU Y ， et al . A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus ［J］. Diabetologia ， 2012 ， 55 （ 2 ）： 499 - 508 .

HANDZLIK M K ， GENGATHARAN J M ， FRIZZI K E ， et al . Insulin-regulated serine and lipid metabolism drive peripheral neuropathy ［J］. Nature ， 2023 ， 614 （ 7946 ）： 118 - 124 .

TANG Q ， TAN P ， MA N ， et al . Physiological functions of threonine in animals：Beyond nutrition metabolism ［J］. Nutrients ， 2021 ， 13 （ 8 ）： 2592 .

CHEN J ， QIAN D ， WANG Z ， et al . Threonine supplementation prevents the development of fat deposition in mice fed a high-fat diet ［J］. Food Funct ， 2022 ， 13 （ 14 ）： 7772 - 7780 .

ADEVA-ANDANY M ， SOUTO-ADEVA G ， AMENEIROS-RODRíGUEZ E ， et al . Insulin resistance and glycine metabolism in humans ［J］. Amino Acids ， 2018 ， 50 （ 1 ）： 11 - 27 .

YAN-DO R ， DUONG E ， MANNING FOX J E ， et al . A glycine-insulin autocrine feedback loop enhances insulin secretion from human β -cells and is impaired in type 2 diabetes ［J］. Diabetes ， 2016 ， 65 （ 8 ）： 2311 - 2321 .

YAN D R ， MACDONALD P E . Impaired "glycine"-mia in type 2 diabetes and potential mechanisms contributing to glucose homeostasis ［J］. Endocrinology ， 2017 ， 158 （ 5 ）： 1064 - 1073 .

QI Q ， LI J ， YU B ， et al . Host and gut microbial tryptophan metabolism and type 2 diabetes：An integrative analysis of host genetics，diet，gut microbiome and circulating metabolites in cohort studies ［J］. Gut ， 2022 ， 71 （ 6 ）： 1095 - 1105 .

DU W ， JIANG S ， YIN S ， et al . The microbiota-dependent tryptophan metabolite alleviates high-fat diet-induced insulin resistance through the hepatic AhR/TSC2/mTORC1 axis ［J］. Proc Natl Acad Sci USA ， 2024 ， 121 （ 35 ）： e2400385121 .

YU E ， PAPANDREOU C ， RUIZ-CANELA M ， et al . Association of tryptophan metabolites with incident type 2 diabetes in the PREDIMED trial：A case-cohort study ［J］. Clin Chem ， 2018 ， 64 （ 8 ）： 1211 - 1220 .

Views

269

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Sequential Administration of Dihuang Baoyuan Granules and Fuling Yunhua Granules for Teating Type 2 Diabetes Mellitus in Mice

Role of Modified Sanjiasan in Improving Ovarian Dysfunction in Diabetic Mice via Modulating Inflammatory Mechanism and Microangiogenesis

Mechanism of Qijiang Yimai Prescription in Delaying Vascular Aging of Type 2 Diabetes Mellitus Rats by Regulating FGF21/AMPK Pathway and Enhancing Mitophagy

Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway

Effect and Mechanism of Liangyi Paste on Hepatic Lipid Deposition in Naturally Aged Mice with High-fat Diet via Cuproptosis/Oxidative Stress Pathway

Related Author

XIE Huiyi

CHEN Junran

HUANG Boning

YANG Xinrong

LIU Fangle

ZHENG Yuying

ZHAO Haiyu

HU Tianbao

Related Institution

The First Affiliated Hospital of Guangzhou University of Chinese Medicine， Guangdong Clinical Research Academy of Chinese Medicine， Guangdong Engineering Research Center of Commercialization of Medical Institution Preparations and Traditional Chinese Medicines， Guangdong Engineering Technology Research Center of Commercialization of Linnan Special Medical Institution Preparations

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences

Hu Tianbao Community-Level Old Chinese Medicine Studio

Hunan University of Chinese Medicine

Beijing University of Chinese Medicine

AI脑图

AI问答

Address：No. 16, Nanxiaojie, Dongzhimennei, Beijing Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰